₹ 2,524.80
24.60 (0.98%)
G
GlaxoSmithKline Pharmaceuticals
₹ 2,524.80
GlaxoSmithKline Pharmaceuticals Share Price Today
GlaxoSmithKline Pharmaceuticals (GLAXO) share price is trading at ₹2,524.80 on the NSE as of November 6, 2026 at 03:54 PM, up by 0.98% from its previous close of ₹2,500.20. In todays trading session GLAXO reached a high of 2,544.80 and low of 2,489.30. The average traded price for today is 2,515.95. The 50 DMA stands at 2,722.42 and 200 DMA is at 2,516.91. Looking at intraday trend, the stock is moving sideways.
Stock Overview
- Symbol : GLAXO
- Open : ₹2,502.00
- Previous Close : ₹2,500.20
- Day's Range : ₹2,489.30 – ₹2,544.80
- 52-Week Range : ₹2,088.10 – ₹3,120.70
Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.
GLAXO Stock Performance
Markets Today
High
2,544.80
Low
2,489.30
Open at
2,502.00
Prev Close
2,500.20
Volumes
1,17,398
Avg Price
2,515.95
Lower Circuit
2,019.90
Upper Circuit
3,029.70
Last Traded Details
Quantity
1
Time
15:54:13
Price Movement
Historical Performance
3 M High
3,120.70
3 M Low
2,344.10
1 Yr High
3,120.70
1 Yr Low
2,088.10
3 Yr High
3,515.70
3 Yr Low
1,408.15
5 Yr High
3,515.70
5 Yr Low
1,227.00
1-Year Performance
GLAXO Pros and Cons
Revenue grew from ₹924 Cr in Q1 FY26 to ₹1,180 Cr in Q2 FY26 — strongest top-line performance in the period
PAT rose from ₹253 Cr in Q1 FY26 to ₹335 Cr in Q2 FY26 — bottom-line recovery driven by volume and margin gains
T-Bact value index climbed from 101x in Q4 FY25 to 105x in Q1 FY26 — sustained premium pricing power
PAT margin improved from 27.6% in Q1 FY26 to 29% in Q2 FY26 — operational efficiency boosting profitability
Established Vaccines market share fell from 26.1% in Q1 FY26 to 21.5% in Q2 FY26 — volatility in vaccine demand
EBITDA margin dipped to 31.7% in Q1 FY26 from 35.2% in Q4 FY25 — cost pressures impacted interim profitability
GLAXO Analyst Rating
Buy
Analysts have suggested that investors can
Buy this Stock
- By Refinitiv from 4 analysts
Buy
75%
Hold
25%
Sell
0%
Get forecast for Price, ROA & ROE based on analyst ratings.
GLAXO Share Price History
GLAXO Fundamentals
Company Valuation
Market Cap (₹ Cr.)
42,772
PE Ratio
37.00
PB Ratio
22.52
Dividend Yield
2.28%
ROE
45.69%
ROCE
55.36%
Book Value (₹)
111.04
Face Value (₹)
10.00
Analyse GLAXO with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% |
| Domestic Institutional Investors (DII) | 7.75% | 7.70% | 7.68% | 7.80% | 8.48% |
| Foreign Institutional Investors (FII) | 4.80% | 4.64% | 4.62% | 4.79% | 4.75% |
| Public Investors | 10.34% | 10.36% | 10.35% | 10.21% | 9.65% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
GlaxoSmithKline Pharmaceuticals Return Calculator
Note: Past profits do not guarantee future returns.
GLAXO Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
GLAXO Technicals
Moving Averages
Technical Indicators
Summary of Technical Indicators for GLAXO
Margin on GLAXO
*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).
GLAXO Financials Summary
In Crores
GLAXO Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Corporate Actions
The above dates are ex-dates.
Check GLAXO latest Company Filings, Investor Presentation & Conference Call details.
GLAXO Revenue Growth
All values are in Crores
Revenue
Profit
Loss
GLAXO Similar Stocks
FAQs on GLAXO
What is the share price of GlaxoSmithKline Pharmaceuticals?
What is the 52W high and 52W low of GlaxoSmithKline Pharmaceuticals?
What is the return on GlaxoSmithKline Pharmaceuticals share?
- Past 1 year: -5.03%
- Past 3 years: 79.68%
- Past 5 years: 52.24%
What is the PE and PB Ratio of GlaxoSmithKline Pharmaceuticals?
What is the EPS of GlaxoSmithKline Pharmaceuticals?
What is the shareholding pattern of GlaxoSmithKline Pharmaceuticals?
- DIIs - 8.48%
- FII - 4.75%
- Promoters - 75.00%
- Public Investors 9.65%
- Goverenment - 0.00%
How to buy GlaxoSmithKline Pharmaceuticals shares online?
How to buy GlaxoSmithKline Pharmaceuticals shares on Dhan?
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for GlaxoSmithKline Pharmaceuticals share
- Tap on “Buy”
